152 related articles for article (PubMed ID: 38462350)
1. [Prevention and treatment of endometrial cancer].
Kong BH; Song K; Yin AJ
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):715-720. PubMed ID: 38462350
[TBL] [Abstract][Full Text] [Related]
2. Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?
Marnitz S; Köhler C; Gharbi N; Kunze S; Jablonska K; Herter J
Strahlenther Onkol; 2018 Nov; 194(11):965-974. PubMed ID: 30112692
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
4. Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer.
Nakayama K; Nagai Y; Ishikawa M; Aoki Y; Miyazaki K
Int J Clin Oncol; 2010 Oct; 15(5):440-6. PubMed ID: 20419386
[TBL] [Abstract][Full Text] [Related]
5. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary study of sequential multi-modality adjuvant chemotherapy and radiation for advanced endometrial cancer].
Zhang G; Suo HY; Shen XY; Zhao LJ; Wang ZQ; Kong WM; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 Feb; 54(2):103-109. PubMed ID: 30803169
[No Abstract] [Full Text] [Related]
7. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Forsse D; Berg HF; Bozickovic O; Engerud H; Halle MK; Hoivik EA; Woie K; Werner HMJ; Haldorsen IS; Trovik J; Krakstad C
Gynecol Oncol; 2021 Feb; 160(2):396-404. PubMed ID: 33317908
[TBL] [Abstract][Full Text] [Related]
8. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.
Eggink FA; Mom CH; Boll D; Ezendam NPM; Kruitwagen RFPM; Pijnenborg JMA; van der Aa MA; Nijman HW
Gynecol Oncol; 2017 Aug; 146(2):380-385. PubMed ID: 28552255
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Features of Recurrent Endometrial Cancer in Japan: Chemotherapy Instead of Radiotherapy as Postoperative Adjuvant Treatment.
Iwase H; Furukawa S; Hirasawa T; Asai S; Ohara T; Hosonuma S; Endo S; Tazo Y; Sato H; Takada T; Arai M; Ikeda M; Shida M; Yoshioka N; Tozawa-Ono A; Suzuki N; Mikami M; Onda T
Int J Gynecol Cancer; 2018 Oct; 28(8):1616-1623. PubMed ID: 30095709
[TBL] [Abstract][Full Text] [Related]
11. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract][Full Text] [Related]
13. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
14. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
15. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
16. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
17. Changing concepts in the management of endometrial cancer.
Karasek K; Faul C
Oncology (Williston Park); 1996 Jul; 10(7):1099-106, 1110; disc. 1112, 1115. PubMed ID: 8837124
[TBL] [Abstract][Full Text] [Related]
18. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
19. Current recommendations and recent progress in endometrial cancer.
Brooks RA; Fleming GF; Lastra RR; Lee NK; Moroney JW; Son CH; Tatebe K; Veneris JL
CA Cancer J Clin; 2019 Jul; 69(4):258-279. PubMed ID: 31074865
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant treatments for endometrial cancer].
Meillan N
Rev Prat; 2022 Sep; 72(7):743-746. PubMed ID: 36511961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]